Cara Therapeutics | CARA - Current Assets

Stock Price
3.17
Daily Change
-0.16 -4.80%
Monthly
-19.95%
Yearly
-79.48%
Q1 Forecast
3.19

Cara Therapeutics reported $43.13M in Current Assets for its fiscal quarter ending in June of 2025.





Current Assets Change Date
Acadia Pharmaceuticals USD 1.06B 14.31M Dec/2025
Alterity Therapeutics Limited AUD 27.05M 6.16M Jun/2023
Assertio Holdings USD 263.57M 53.36M Sep/2025
Cara Therapeutics USD 43.13M 4.18M Jun/2025
Cassava Sciences USD 97.71M 11.2M Dec/2025
Chugai Pharma JPY 1.74T 223.03B Dec/2025
Cipla INR 249.18B 16.3B Sep/2025
Clal Biotechnology ILS 14.69M 1.95M Dec/2023
Compugen USD 148.02M 59.1M Dec/2025
CSL USD 11.85B 1000K Dec/2025
Grifols EUR 5.96B 316.31M Dec/2025
Halozyme Therapeutics USD 825.21M 503.54M Dec/2025
J&J USD 55.62B 1.01B Dec/2025
Neurocrine Biosciences USD 2.52B 364.3M Dec/2025
Pacira USD 547.97M 14.78M Dec/2025
Pfizer USD 46.92B 3.22B Sep/2025
RedHill Biopharma USD 12.56M 644K Jun/2025
Supernus Pharmaceuticals USD 644.18M 50.29M Dec/2025
Vanda Pharmaceuticals USD 347.26M 20.23M Dec/2025